Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: Systematic review and meta-analysis

International Journal of Technology Assessment in Health Care

Volumn 27, Issue 1, 2011, Pages 3-10

  Mowatt, Graham ^a   N'Dow, James ^b,c   Vale, Luke ^a   Nabi, Ghulam ^d   Boachie, Charles ^a   Cook, Jonathan A ^a   Fraser, Cynthia ^a   Griffiths, T R Leyshon ^e,f  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

^f LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Bladder cancer; Diagnostic tests; Meta analysis; Systematic review

Indexed keywords

5-AMINOLAEVULINIC ACID; BLADDER CANCERS; BLADDER TUMOR; CLINICAL EFFECTIVENESS; COMPARATIVE STUDIES; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DIAGNOSTIC TESTS; ELECTRONIC DATABASE; META-ANALYSIS; PHOTODYNAMIC DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; RECURRENCE-FREE SURVIVAL; RELATIVE RISKS; RESIDUAL TUMORS; SYSTEMATIC REVIEW; TEST PERFORMANCE; TRANSURETHRAL RESECTIONS; WHITE LIGHT;

DISEASES; TUMORS; USER INTERFACES;

ENDOSCOPY;

AMINOLEVULINIC ACID; HEXAMINOLAEVULINATE; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT;

BLADDER CANCER; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; COCHRANE LIBRARY; CROSS-SECTIONAL STUDY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ELECTRONIC DATA INTERCHANGE; EMBASE; HUMAN; INTERMETHOD COMPARISON; MEDICAL LITERATURE; MEDLINE; PHOTODYNAMICS; RECURRENCE FREE SURVIVAL; RECURRENT CANCER; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL; SYSTEMATIC REVIEW; TRANSURETHRAL RESECTION; WHITE LIGHT CYSTOSCOPY; BLADDER TUMOR; COMPARATIVE STUDY; META ANALYSIS; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARD; UROLOGIC EXAMINATION;

CYSTOSCOPY; DIAGNOSTIC TECHNIQUES, UROLOGICAL; HUMANS; PHOTOSENSITIZING AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 79955703830     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462310001364     Document Type: Review

References (18)

1. Babjuk M, Oosterlinck W, Sylvester R, et al. Guidelines on TaT1 (non-muscle-invasive) bladder cancer. Arnhem: Eu¬ropean Association of Urology; 2009. http://www.uroweb. org/fileadmin/tx-eauguidelines/2009/Full/TaT1- BC.pdf (ac¬cessed January 2010).
2. Babjuk M, Soukup V, Petrik R, Jirsa M, Dvoracek J. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer. BJU Int. 2005;96:798-802. (Pubitemid 41391384)
3. Cancer Research UK. UK bladder cancer statistics. 2010. http://info.cancerresearchuk.org/cancerstats/types/bladder/?a= 5441 (accessed January 2010).
4. Hendricksen K, Moonen PM, der Heijden AG, Witjes JA. False-positive lesions detected by fluorescence cystoscopy: Any association with p53 and p16 expression? World J Urol. 2006;24:597-601. (Pubitemid 44782314)
5. Jichlinski P, Wagnieres G, Forrer M, et al. Clinical assessment of fluorescence cytoscopy during transurethral bladder resec¬tion in superficial bladder cancer. Urol Res. 1997;25:S3-S6. (Pubitemid 27139697)
6. Kausch I, Sommerauer M, Montorsi F, et al. Photodynamic diagnosis in non-muscle-invasive bladder cancer: A systematic review and cumulative analysis ofprospective studies. Eur Urol. 2010;57:595-606.
7. Koenig F, McGovern FJ, Larne R, et al. Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid. BJU Int. 1999;83:129-135. (Pubitemid 29151420)
8. Kriegmair M, Zaak D, Rothenberger KH, et al. Transurethral resection for bladder cancer using 5-aminolevulinic acid in¬duced fluorescence endoscopy versus white light endoscopy. J Urol. 2002;168:475-478. (Pubitemid 34793275)
9. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM, Cochrane Diagnostic Test Accuracy Working Group. Systematic reviews of diagnostic test accuracy. Ann Intern Med. 2008;149:889-897.
10. Macaskill P. Empirical Bayes estimates generated in a hierar¬chical summary ROC analysis agreed closely with those of a full Bayesian analysis. J Clin Epidemiol. 2004;57:925-932.
11. Masters JRW, Popert RJM, Thompson PM, et al. Intravesical chemotherapy with epirubicin: A dose response study. J Urol. 1999;161:1490-1493. (Pubitemid 29420802)
12. Mowatt G, Zhu S, Kilonzo M, et al. Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer. Health Technol Assess. 2010;14:1-331, iii-iv.
13. Sangar VK, Ragavan N, Matanhelia SS, Watson MW, Blades RA. The economic consequences of prostate and bladder cancer in the UK. BJU Int. 2005;95:59-63. (Pubitemid 350020870)
14. Stenzl AS, Roessler WR, Fradet YF, et al. HEXVIX fluores¬cence cystoscopy improves detection and resection of papillary bladder cancer and reduces early recurrence: A multicentre prospective randomized trial. Abstract 1010. Eur Urol Suppl. 2009;8:373.
15. Sylvester RJ, Oosterlinck W. An immediate instillation af¬ter transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: Has the evidence changed? Eur Urol. 2009;56:43-45.
16. Sylvester RJ, Oosterlinck W, Van Der Meijden APM. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: A meta-analysis of published results of randomized clinical trials. J Urol. 2004;171:2186-2190. (Pubitemid 38625431)
17. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: A tool for the quality assess¬ment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.
18. Zaak D, Karl A, Knuchel R, et al. Diagnosis of urothelial car¬cinoma of the bladder using fluorescence endoscopy. BJU Int. 2005;96:217-222. (Pubitemid 41097708)